These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Genomic Characterization of Vulvar (Pre)cancers Identifies Distinct Molecular Subtypes with Prognostic Significance. Nooij LS; Ter Haar NT; Ruano D; Rakislova N; van Wezel T; Smit VTHBM; Trimbos BJBMZ; Ordi J; van Poelgeest MIE; Bosse T Clin Cancer Res; 2017 Nov; 23(22):6781-6789. PubMed ID: 28899974 [No Abstract] [Full Text] [Related]
7. Single-cell Atlas of Penile Cancer Reveals TP53 Mutations as a Driver of an Aggressive Phenotype, Irrespective of Human Papillomavirus Status, and Provides Clues for Treatment Personalization. Elst L; Philips G; Vandermaesen K; Bassez A; Lodi F; Vreeburg MTA; Brouwer OR; Schepers R; Van Brussel T; Mohanty SK; Parwani AV; Spans L; Vanden Bempt I; Jacomen G; Baldewijns M; Lambrechts D; Albersen M Eur Urol; 2024 Aug; 86(2):114-127. PubMed ID: 38670879 [TBL] [Abstract][Full Text] [Related]
8. Analysis of full coding sequence of the TP53 gene in invasive vulvar cancers: Implications for therapy. Kashofer K; Regauer S Gynecol Oncol; 2017 Aug; 146(2):314-318. PubMed ID: 28527674 [TBL] [Abstract][Full Text] [Related]
10. HPV-positive clinically advanced squamous cell carcinoma of the urinary bladder (aBSCC): A comprehensive genomic profiling (CGP) study. Ghelani GH; Zerdan MB; Jacob J; Spiess PE; Li R; Necchi A; Grivas P; Kamat A; Danziger N; Lin D; Huang R; Decker B; Sokol ES; Cheng L; Pavlick D; Ross JS; Bratslavsky G; Basnet A Urol Oncol; 2023 Dec; 41(12):486.e15-486.e23. PubMed ID: 37821306 [TBL] [Abstract][Full Text] [Related]
11. Molecular landscape of vulvovaginal squamous cell carcinoma: new insights into molecular mechanisms of HPV-associated and HPV-independent squamous cell carcinoma. Salama AM; Momeni-Boroujeni A; Vanderbilt C; Ladanyi M; Soslow R Mod Pathol; 2022 Feb; 35(2):274-282. PubMed ID: 34650187 [TBL] [Abstract][Full Text] [Related]
12. p53 and p16 expression profiles in vulvar cancer: a translational analysis by the Arbeitsgemeinschaft Gynäkologische Onkologie Chemo and Radiotherapy in Epithelial Vulvar Cancer study group. Woelber L; Prieske K; Eulenburg C; Oliveira-Ferrer L; de Gregorio N; Klapdor R; Kalder M; Braicu I; Fuerst S; Klar M; Strauss HG; Beckmann M; Meier W; Ignatov A; Mustea A; Jueckstock J; Schmidt G; Bauerschlag D; Hellriegel M; Canzler U; Petry KU; Kommoss S; Hantschmann P; Heubner M; Mahner S; Burandt E Am J Obstet Gynecol; 2021 Jun; 224(6):595.e1-595.e11. PubMed ID: 33453182 [TBL] [Abstract][Full Text] [Related]
13. Vulvar Squamous Cell Carcinoma (VSCC) as Two Diseases: HPV Status Identifies Distinct Mutational Profiles Including Oncogenic Fibroblast Growth Factor Receptor 3. Weberpals JI; Lo B; Duciaume MM; Spaans JN; Clancy AA; Dimitroulakos J; Goss GD; Sekhon HS Clin Cancer Res; 2017 Aug; 23(15):4501-4510. PubMed ID: 28377483 [No Abstract] [Full Text] [Related]
14. p53 mutations and clonality in vulvar carcinomas and squamous hyperplasias: evidence suggesting that squamous hyperplasias do not serve as direct precursors of human papillomavirus-negative vulvar carcinomas. Kim YT; Thomas NF; Kessis TD; Wilkinson EJ; Hedrick L; Cho KR Hum Pathol; 1996 Apr; 27(4):389-95. PubMed ID: 8617483 [TBL] [Abstract][Full Text] [Related]
15. Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classes. Chung JH; Sanford E; Johnson A; Klempner SJ; Schrock AB; Palma NA; Erlich RL; Frampton GM; Chalmers ZR; Vergilio J; Rubinson DA; Sun JX; Chmielecki J; Yelensky R; Suh JH; Lipson D; George TJ; Elvin JA; Stephens PJ; Miller VA; Ross JS; Ali SM Ann Oncol; 2016 Jul; 27(7):1336-41. PubMed ID: 27052656 [TBL] [Abstract][Full Text] [Related]
16. Expanding the Morphologic, Immunohistochemical, and HPV Genotypic Features of High-grade Squamous Intraepithelial Lesions of the Vulva With Morphology Mimicking Differentiated Vulvar Intraepithelial Neoplasia and/or Lichen Sclerosus. Griesinger LM; Walline H; Wang GY; Lorenzatti Hiles G; Welch KC; Haefner HK; Lieberman RW; Skala SL Int J Gynecol Pathol; 2021 May; 40(3):205-213. PubMed ID: 32925443 [TBL] [Abstract][Full Text] [Related]
17. HPV-independent, p53-wild-type vulvar intraepithelial neoplasia: a review of nomenclature and the journey to characterize verruciform and acanthotic precursor lesions of the vulva. Parra-Herran C; Nucci MR; Singh N; Rakislova N; Howitt BE; Hoang L; Gilks CB; Bosse T; Watkins JC Mod Pathol; 2022 Oct; 35(10):1317-1326. PubMed ID: 35437330 [TBL] [Abstract][Full Text] [Related]
18. Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas. Seiwert TY; Zuo Z; Keck MK; Khattri A; Pedamallu CS; Stricker T; Brown C; Pugh TJ; Stojanov P; Cho J; Lawrence MS; Getz G; Brägelmann J; DeBoer R; Weichselbaum RR; Langerman A; Portugal L; Blair E; Stenson K; Lingen MW; Cohen EE; Vokes EE; White KP; Hammerman PS Clin Cancer Res; 2015 Feb; 21(3):632-41. PubMed ID: 25056374 [TBL] [Abstract][Full Text] [Related]
19. Mutational profiles of head and neck squamous cell carcinomas based upon human papillomavirus status in the Veterans Affairs National Precision Oncology Program. Doerstling S; Winski D; Katsoulakis E; Agarwal P; Poonnen PJ; Snowdon JL; Jackson GP; Weeraratne D; Kelley MJ; Vashistha V J Cancer Res Clin Oncol; 2023 Jan; 149(1):69-77. PubMed ID: 36117189 [TBL] [Abstract][Full Text] [Related]